You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API brivaracetam


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing brivaracetam

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
UCB Inc BRIVIACT brivaracetam 50474-370 ANHYDROUS LACTOSE
UCB Inc BRIVIACT brivaracetam 50474-370 BETADEX
UCB Inc BRIVIACT brivaracetam 50474-370 CROSCARMELLOSE SODIUM
UCB Inc BRIVIACT brivaracetam 50474-370 LACTOSE MONOHYDRATE
UCB Inc BRIVIACT brivaracetam 50474-370 MAGNESIUM STEARATE
UCB Inc BRIVIACT brivaracetam 50474-370 POLYETHYLENE GLYCOL 3350
UCB Inc BRIVIACT brivaracetam 50474-370 POLYVINYL ALCOHOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing brivaracetam

Company Ingredient NDC Excipient
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 CARBOXYMETHYLCELLULOSE SODIUM
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 CITRIC ACID
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 GLYCERIN
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 METHYLPARABEN
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 SODIUM CITRATE
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 SORBITOL SOLUTION
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074 SUCRALOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for brivaracetam

Excipient focus: ACETIC ACID

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

brivaracetam drug variants not containing ANHYDROUS LACTOSE

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Apotex Corp brivaracetam 60505-4723
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: BETADEX

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID

Excipient focus: CROSCARMELLOSE SODIUM

brivaracetam drug variants not containing CROSCARMELLOSE SODIUM

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
PAI Holdings LLC dba PAI Pharma brivaracetam injection 0121-1075
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONO AND DICAPRYLOCAPRATE

Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE

brivaracetam drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
UCB Inc brivaracetam 50474-370
Apotex Corp brivaracetam 60505-4723
Ascend Laboratories LLC brivaracetam 67877-904
Zydus Pharmaceuticals USA Inc brivaracetam 70710-1584
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: LACTOSE MONOHYDRATE

brivaracetam drug variants not containing LACTOSE MONOHYDRATE

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
PAI Holdings LLC dba PAI Pharma brivaracetam injection 0121-1075
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: MAGNESIUM STEARATE

brivaracetam drug variants not containing MAGNESIUM STEARATE

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
PAI Holdings LLC dba PAI Pharma brivaracetam injection 0121-1075
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: METHYLPARABEN

Excipient focus: METHYLPARABEN SODIUM

Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION

brivaracetam drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
UCB Inc brivaracetam 50474-370
Apotex Corp brivaracetam 60505-4723
Zydus Pharmaceuticals USA Inc brivaracetam 70710-1584
Zydus Lifesciences Limited brivaracetam 70771-1754
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

brivaracetam drug variants not containing POLYETHYLENE GLYCOL 3350

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Zydus Pharmaceuticals USA Inc brivaracetam 70710-1584
Zydus Lifesciences Limited brivaracetam 70771-1754
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-267
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POLYVINYL ALCOHOL

brivaracetam drug variants not containing POLYVINYL ALCOHOL

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-267
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: SUCRALOSE

Excipient focus: TALC

brivaracetam drug variants not containing TALC

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
PAI Holdings LLC dba PAI Pharma brivaracetam injection 0121-1075
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: TITANIUM DIOXIDE

brivaracetam drug variants not containing TITANIUM DIOXIDE

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
PAI Holdings LLC dba PAI Pharma brivaracetam injection 0121-1075
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

brivaracetam drug variants containing WATER

Company Ingredient NDC
PAI Holdings LLC dba PAI Pharma brivaracetam 0121-1074
Hainan Poly Pharm Co Ltd brivaracetam 14335-420
Ascend Laboratories LLC brivaracetam 67877-904
Novadoz Pharmaceuticals LLC brivaracetam 72205-033
Novadoz Pharmaceuticals LLC brivaracetam 72205-272
Zhejiang Poly Pharm Co Ltd brivaracetam 72673-031
PAI Holdings LLC dba PAI Pharma brivaracetam injection 0121-1075
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links